Kolodziejczyk P, Kulig J, Popiela T, Sierzega M, Jedrys J, Czupryna A, Kubisz A, Szczepanik A, Klek Stanislaw
1st Department of General and Gastrointestinal Surgery, Jagiellonian University, Krakow, Poland.
Hepatogastroenterology. 2005 Nov-Dec;52(66):1911-5.
BACKGROUND/AIMS: The aim of the study was to review cases of gastric cancers in elderly adults (70 years of age and older), and compare demographic, clinical, pathologic features and outcomes of surgical treatment with younger patients (below 70 years of age).
The analysis included 3431 patients treated for gastric cancer between 1977 and 1998 at eight university surgical centers cooperating for the Polish Gastric Cancer Study Group (PGCSG). Patients were analyzed retrospectively according to data obtained from standardized forms and divided into two groups: group I--patients 70 years of age and over, group II--younger patients.
There were no significant differences between these two groups in clinical symptoms at the time of diagnosis and tumor advancement. The incidence of the intestinal type according to Lauren (55.9% vs. 43.9%;p<0.05) and distally-located cancers (40.8% vs. 31.3%; p<0.05) was higher in group I. Total gastrectomies and extended lymph node dissection were performed more often in younger patients. There were no significant differences in postoperative complications between both groups, except the higher incidence of abdominal abscesses in the younger group. The overall 5-year survival was 24% and 35% for group I and II, respectively (p<0.05), and increased to 35% and 53% after radical resections, respectively. However, there were no statistically significant differences in stage-specific survival between both groups.
Surgical resection is the method of choice in the treatment of gastric cancer. Age of the patients is not a contraindication to surgical treatment of gastric cancer.
背景/目的:本研究旨在回顾老年(70岁及以上)胃癌患者的病例,并比较其人口统计学、临床、病理特征以及与年轻患者(70岁以下)手术治疗的结果。
分析纳入了1977年至1998年期间在波兰胃癌研究组(PGCSG)合作的八所大学外科中心接受胃癌治疗的3431例患者。根据标准化表格获得的数据对患者进行回顾性分析,并分为两组:第一组为70岁及以上的患者,第二组为年轻患者。
两组在诊断时的临床症状和肿瘤进展方面无显著差异。第一组中Lauren肠型(55.9%对43.9%;p<0.05)和远端癌(40.8%对31.3%;p<0.05)的发生率较高。年轻患者更常进行全胃切除术和扩大淋巴结清扫术。两组术后并发症无显著差异,但年轻组腹部脓肿的发生率较高。第一组和第二组的总体5年生存率分别为24%和35%(p<0.05),根治性切除后分别提高到35%和53%。然而,两组在特定分期生存率方面无统计学显著差异。
手术切除是胃癌治疗的首选方法。患者年龄并非胃癌手术治疗的禁忌证。